Bongo Rx Preferred Over Traditional CPAP to Treat Sleep Apnea

DEERFIELD BEACH, Fla., Sept. 20, 2019 /PRNewswire/ -- According to a recent Qualtrics Survey conducted September 4th though September 11th, of over 200 respondents with mild to moderate sleep apnea, more than 70% said they would prefer to try the FDA cleared Bongo Rx over traditional CPAP therapy to treat their sleep apnea when given the choice.

Metadata
Provider: 
PR Newswire
Retrieved on: 
Friday, September 20, 2019
Information
Tags: 
Medicine, Sleep disorders, Clinical medicine, Medical equipment, Health, Continuous positive airway pressure, Mechanical ventilation, Fisher & Paykel Healthcare, Respironics, ResMed, Sleep apnea, CPAP
Geotags: 
Florida
Organisation: 
AIRAVANT MEDICAL
Website: 
http://www.airavant.com
Summary
Key Points: 
  • DEERFIELD BEACH, Fla., Sept. 20, 2019 /PRNewswire/ -- According to a recent Qualtrics Survey conducted September 4th though September 11th, of over 200 respondents with mild to moderate sleep apnea, more than 70% said they would prefer to try the FDA cleared Bongo Rx over traditional CPAP therapy to treat their sleep apnea when given the choice.
  • The Bongo Rx is a small, discreet nasal device that requires no CPAP machine, CPAP mask, CPAP hose, bulky headgear, electricity or battery power.
  • The survey results highlight this new sleep apnea therapy device when compared to traditional CPAP machines and masks marketed by industry leaders such as: ResMed, Phillips Respironics, and Fisher & Paykel Healthcare Corporation Limited.
  • Industry experts estimate that approximately 50% of CPAP patients on average will eventually abandon their CPAP therapy and become non-compliant.


Bongo Rx Preferred Over Traditional CPAP to Treat Sleep Apnea

DEERFIELD BEACH, Fla., Sept. 20, 2019 /PRNewswire/ -- According to a recent Qualtrics Survey conducted September 4th though September 11th, of over 200 respondents with mild to moderate sleep apnea, more than 70% said they would prefer to try the FDA cleared Bongo Rx over traditional CPAP therapy to treat their sleep apnea when given the choice.

The Bongo Rx is a small, discreet nasal device that requires no CPAP machine, CPAP mask, CPAP hose, bulky headgear, electricity or battery power.

The survey results highlight this new sleep apnea therapy device when compared to traditional CPAP machines and masks marketed by industry leaders such as: ResMed, Phillips Respironics, and Fisher & Paykel Healthcare Corporation Limited. Industry experts estimate that approximately 50% of CPAP patients on average will eventually abandon their CPAP therapy and become non-compliant.

"I feel the results of this Qualtrics Survey reflect that mild to moderate OSA sufferers want a simple and effective alternative to traditional CPAP. Over 70% of the respondents in this survey chose Bongo Rx. It's gratifying that years of effort by our team to develop the Bongo Rx have yielded such a great outcome," says Bruce Sher, President of AirAvant Medical, maker of the Bongo Rx.

About AirAvant Medical:

AirAvant Medical (www.AirAvant.com) is a research-oriented, privately held company that focuses on developing and marketing innovative medical devices to treat obstructive sleep apnea and other breathing disorders. AirAvant Medical holds numerous patents and has several patents pending. This newly formed company was created from the former partners of InnoMed Technologies, Inc., as well as Ron F. Richard formerly of ResMed and SeQual Technologies. InnoMed Technologies past achievements included a highly acclaimed line of Respiratory and Sleep Devices, such as the Nasal-Aire®, the Hybrid, and the Aloha line of CPAP interfaces.

Contact:
Elena Hartmanis
EMI Group, Inc.
[email protected] 
561-756-5551

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/bongo-rx-preferred-over-traditional-cpap-to-treat-sleep-apnea-300922346.html

SOURCE AirAvant Medical

Copyright: 
2019 PR Newswire. All Rights Reserved.